YAL
MED icon

Your Advocates Ltd’s Medifast MED Stock Holding History

Your Advocates Ltd’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-17
Closed -$231 – 208
2025
Q1 		$231 Sell
17
-10
-37% -$150 ﹤0.01% 192
2024
Q4 		$479 Hold
27
– – ﹤0.01% 184
2024
Q3 		$520 Hold
27
– – ﹤0.01% 204
2024
Q2 		$593 Buy
27
+20
+286% +$533 ﹤0.01% 204
2024
Q1 		$275 Hold
7
– – ﹤0.01% 210
2023
Q4 		$482 Hold
7
– – ﹤0.01% 210
2023
Q3 		$524 Buy
+7
New +$621 ﹤0.01% 239

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Your Advocates Ltd's MED Position: Q2 2025 in Review

Your Advocates Ltd sold out of Medifast (MED) in Q2 2025, closing a stake of 17 shares — an estimated $231 sold.

Your Advocates Ltd first reported a position in MED in Q3 2023 and held it in 7 quarters. The position peaked at $593 in Q2 2024. 120 funds tracked by Wall St. Rank hold MED as of Q2 2025.

  • Your Advocates Ltd reported no remaining Medifast position as of Q2 2025 after selling out during the quarter.
  • Your Advocates Ltd sold 17 Medifast shares in Q2 2025, an estimated $231.
  • Your Advocates Ltd first reported a position in Medifast in Q3 2023 and held it in 7 quarters.
  • Your Advocates Ltd's Medifast position peaked at $593 in Q2 2024.
  • 120 funds tracked by Wall St. Rank held Medifast as of Q2 2025.

Based on Your Advocates Ltd's 13F filing for Q2 2025, filed 8 Aug 2025.